Ametek downgraded to Hold from Buy at Melius Research

Melius Research downgraded Ametek (AME) to Hold from Buy with a $192 price target While Melius continues to see Ametek as a core holding, the firm doesn’t have a compelling case for outperformance, the analyst tells investors in a research note. This quarter could see some margin relief from tariffs, but the resolution of tariff uncertainty continues to be delayed, while the Big Beautiful Bill has put a lot of uncertainty into clean tech and healthcare end markets, the firm says.